Bayer Aktiengesellschaft (BAYRY)
| Previous close | 8.36 |
| Open | 8.50 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 8.43 - 8.53 |
| 52-week range | 8.31 - 17.00 |
| Volume | |
| Avg. volume | 1,369,332 |
| Market cap | 33.523B |
| Beta (5Y monthly) | 1.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.03 |
| Earnings date | N/A |
| Forward dividend & yield | 0.66 (7.90%) |
| Ex-dividend date | 02 May 2023 |
| 1y target est | 12.08 |
BloombergBayer Sees No Quick Fixes After Bankers Game Out Breakup
(Bloomberg) -- Bayer AG hired several teams of bankers for a strategy simulation game that studied various breakup scenarios, according to people familiar with the matter. Their conclusion: Sweeping changes to the troubled German conglomerate won’t be easy.Most Read from BloombergBillions Wiped Out as Stock-Safety Trade on Wall Street MisfiresMusk’s Cybertruck Is Already a Production Nightmare for TeslaIsrael and Hamas Trade Blame Amid Claims of Truce ViolationsSingapore High Court Grants Injunc
- Financial Times
Bayer chief blames thin drug pipeline on ‘years of under-investment’
Bayer’s chief executive has blamed an “old chemistry mindset” and a chronic lack of investment in research by his predecessors for a thin drug pipeline that has dragged down the group’s share price. Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease. The setback over a drug that was supposed to generate up to €5bn in annual sales at its peak caused Bayer’s already struggling stock to fall 18 per cent in a day.
BloombergBayer’s Outlook Lowered by Moody’s on ‘Credit Negative Events’
(Bloomberg) -- Bayer AG had its outlook lowered to negative from stable by Moody’s Investors Service following a series of drug pipeline and legal setbacks that have sent its shares and bonds tumbling.Most Read from BloombergRussia Downs Drones Over Moscow in Ukrainian Retaliatory StrikeChina Says Multiple Pathogens Are Behind Spike in Respiratory IllnessesSodium in Batteries: Shift May Herald Another ShakeupMarkets Cheer as Milei Drops Dollarization for Macri BrassEverything You Need to Know Ab
